MétaCan
Menu
← Back to cohort

Biphenylindanone A, a prototypical mGlu <sub>2</sub> positive allosteric modulator, alleviates dyskinesia and psychosis in the parkinsonian marmoset

2019· article· en· W3176355311 on OpenAlexafffundabout
Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, Philippe Huot

Bibliographic record

VenueThe FASEB Journal · 2019
Typearticle
Languageen
FieldNeuroscience
TopicNeuroscience and Neuropharmacology Research
Canadian institutionsMcGill University
FundersNatural Sciences and Engineering Research Council of CanadaWeston Brain Institute
KeywordsDyskinesiaMPTPMarmosetAllosteric modulatorBenserazidePsychosisPharmacologyMedicineParkinson's diseaseNeuroscienceCallithrixLevodopaPsychologyAllosteric regulationInternal medicineReceptorPsychiatryBiologyDiseasePrimate

Abstract

fetched live from OpenAlex

Objective To determine the effect of the prototypical and selective metabotropic glutamate 2 (mGlu 2 ) receptor positive allosteric modulator (PAM) biphenylindanone A (BINA) on L‐3,4‐dihydroxyphenylalanine (L‐DOPA)‐induced psychosis‐like behaviours (PLBs) and dyskinesia in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned marmoset model of Parkinson's disease (PD). Background Psychosis and dyskinesia undermine the quality of life of as many as 50–95% of patients with advanced PD. Available therapies are few, and they may elicit important side effects. We have recently demonstrated that activation of mGlu 2 receptors with another prototypical PAM, LY‐487,379, reduces both PLBs and dyskinesia in the MPTP‐lesioned primate. Here, we seek to determine the effects of PAM BINA on these 2 treatment‐related complications, in the MPTP‐lesioned marmoset. Methods Six common marmosets ( Callithrix jacchus ) were rendered parkinsonian by MPTP injection. Following repeated administration of L‐DOPA/benserazide (L‐DOPA) to elicit stable PLBs and dyskinesia, they were administered acute challenges of BINA (0.1, 1 and 10 mg/kg) or vehicle, in combinaison with L‐DOPA after which the severity of PLBs, dyskinesia and parkinsonian disability was rated. Results BINA (0.1, 1 and 10 mg/kg) significantly reduced the severity of peak dose PLBs, by ≈33.3%, ≈ 55.6 and ≈ 61.1% ( P < 0.05, P < 0.01 and P < 0.01), respectively when compared to L‐DOPA/vehicle. Severity of peak dose dyskinesia was also reduced, by ≈ 28.9%, ≈ 52.3 and ≈57.8% ( P < 0.05, P < 0.01 and P < 0.01), respectively, when BINA (0.1, 1 and 10 mg/kg) was added to L‐DOPA, compared to L‐DOPA/vehicle. The anti‐psychotic and anti‐dyskinetic effects of BINA were achieved without interfering with the therapeutic effect of L‐DOPA on parkinsonian disability. Conclusions BINA is the second mGlu 2 PAM that was effective at alleviating PLBs and dyskinesia in the gold‐standard animal model of PD, the parkinsonian primate. The results presented here further add to the increasing data suggesting that mGlu 2 positive allosteric modulation may be effective to diminish both PD psychosis and L‐DOPA‐induced dyskinesia. Support or Funding Information Fonds de Recherche Québec ‐ Santé, Parkinson Canada, Natural Sciences and Engineering Research Council of Canada, Weston Brain Institute, Michael J Fox Foundation for Parkinson's Research, Healthy Brains for Healthy Lives. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.291
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes3
Has abstractyes

Explore more

Same venueThe FASEB Journal→Same topicNeuroscience and Neuropharmacology Research→French-language works237,207→